in fresh dispersion medium containing the enzymes and incubated for an additional 60 min. The fragments were mechanically dispersed by passage through plastic pipettes at 40, 50, and 60 min, filtered through nylon mesh, resuspended in fresh medium and layered over 4% albumin. The resulting suspension was centrifuged, the supernatant was discarded, and the pellet was resuspended in fresh medium and divided into flasks for equilibration in the final incubation medium for 10-1 5 min.
To measure C1 accumulation, 1 pCi/ml of 36Cl (as the NaCl salt, ICN Chemicals, Irvine, CA, sp. act. 18.1 mCi/g) was added to each flask in the absence or in the presence of test substances and samples of the suspension (200 pl) were subsequently removed in duplicate at timed intervals. The cells were separated from the medium by suction filtration through nucleopore filters (25 mm diameter, 3 pM pore size), and the filters were then washed with 10 ml of ice-cold, isotope-free medium. The radioactivity remaining was measured by liquid scintillation spectrometry in a Beckman 380 1 counter. The protein content of appropriate aliquots (0.5 ml) of the various cell suspensions was measured by the Lowry method (21) after sonication of the pellets. Changes in the tracer content of the cells was evaluated in the absence of test substances and in the presence of acetylcholine, caerulein, VIP, and forskolin. The effects of the following transport inhibitors on C1 accumulation were also investigated: amiloride, DIDS, and fuorsemide. The inhibitors were added to the suspensions either at time zero (i.e. just before secretagogue and tracer) or 10 min before.
Values for counts in the various samples removed over the course of the experiments, for total counts added, and for the concentration of non-isotopic C1 in the incubation medium (pmol/ml) were used to calculate a "cold" C1 content of the cells at the different time points according to the formula [C110 cpm sample X 1000 = nmol/mg protein total cpm mg/ml protein Mean values for C1 content at the various times after exposure to tracer and to test substances were calculated from the data of similar experiments and compared by Student's t test. Control experiments to measure basal C1 accumulation were performed with each series of experiments involving drugs. The data from several of these control experiments were pooled in the case of similar drug protocols to generate the graphs shown in "Results" for the two types of acinar preparation. Data for experiments with secretagogues or inhibitors refer to the specific experiments in each case.
RESULTS
Accumulation of CI in absence and presence of secretagogues. A time-dependent accumulation of 36C1 was observed in pancreatic acini of control (untreated) rats not exposed to either secretagogues or transport inhibitors. The values of C1 content calculated as described above from the radiotracer data are shown in Figure 1 . The tracer content (and the calculated C1 content) of the cells rose rapidly upon addition of tracer and was 79 + 5 nmol/mg protein after 1 rnin of incubation and 102 k 6 nmol/ mg protein after 3 min (Fig. 1) . After 5 rnin of incubation, the calculated C1 content was 114 f 7 nmol/mg protein (Fig. 1) . Between 10 and 30 min, the C1 content varied between 1 19 f 8 and 107 +_ 7 nmol/mg protein (Fig. 1) . The mean of the values between 10 and 30 min of incubation was 11 1 +. 4 nmol/mg protein and was considered as a steady state content. The data just described show, therefore, two components of C1 (36Cl) accumulation in unstimulated pancreatic acini of control rats: an initial rate of tracer accumulation (i.e. between 0 and 4-5 min) and a steady state level (i.e. between 10 and 30 rnin). Figure 1 also shows the results of experiments in which control acini were exposed at time zero to either 1 pM acetylcholine or to 10 nM caerulein. Both secretagogues enhanced the initial rate (Fig. 1) . The steady state C1 content (i.e. between 10 and 30 min) in the presence of acetylcholine (135 +_ 2 nmol/mg protein) was also significantly higher ( p = 0.001) than under basal conditions. Similar results were obtained with caerulein, although the effect on steady state accumulation was not as sustained as in the case of acetylcholine (Fig. 1) . The C1 content in the presence of caerulein was 112 f 8 nmol/mg protein after 1 min of incubation and 161 f 10 nmol/mg protein after 5 rnin (Fig. I) .
Both values were significantly higher ( p < 0.05) than the corresponding basal values in the absence of stimulant. The calculated steady state C1 content in the presence of caerulein was 13 1 +. 4 nmol/mg protein, which was also significantly higher ( p = 0.01) than that of unstimulated cells. Figure 2 shows the results of similar experiments with acini of reserpine-treated rats. The same two components of C1 accumulation were observed in cells not exposed to secretagogues. The C1 content of unstimulated cells after 1 rnin of incubation was 65 k 4 nmol/mg protein and, after 5 min, 96 + 3 nmol/mg protein (Fig. 2) . Although the rate of C1 accumulation during the first 5 rnin of incubation appeared similar to that observed in control acini (see Fig. 4 below), the C1 content at early time points (i.e. from 1 to 5 min) was significantly lower than in control acini (compare Figs. 2 and 1). The steady state C1 content in unstimulated acini of reserpine-treated rats was 98 +_ 2 nmol/ mg protein (Fig. 2) . This was also significantly smaller ( p = 0.01) than the steady state C1 content attained in control acini and shown in Figure 1 .
In contrast to control acini, those of reserpine-treated animals did not show an increased C1 accumulation in the presence of secretagogues (Fig. 2) . The C1 content in the presence of 1 pM acetylcholine was 78 f 6 nmol/mg protein after 1 min of incubation and 99 +. 6 nmol/mg protein after 5 min (Fig. 2) . The 1-min value was of borderline significance ( p = 0.05) in relation to the corresponding basal but the 5 rnin value was not significantly different from the 5 min basal ( p = 0.2). Similarly, steady state C1 content in the presence of acetylcholine was not different ( p = 0.2) from that observed in its absence (101 + 3 versus 98 a 2 nmol/mg protein, respectively). Exposure to 10 nM caerulein did not significantly enhance C1 accumulation in the acini of reserpine-treated animals ( Fig. 2) . C1 content values at either the initial period (0-5 min) or the steady state accumulation (105 f 7 nmol/mg protein) were not significantly different than those observed in the absence of caerulein (Fig. 2) .
Effects of DIDS and amiloride. Acini from control and reserpine-treated rats were exposed to either 1 mM DIDS or 1 mM amiloride at time zero (i.e. immediately before tracer) and tracer accumulation was monitored as indicated. The results are shown in Figure 0.01) of incubation than in the absence of the inhibitor. Steady state C1 content was also significantly smaller (p = 0.001) than in cells not exposed to DIDS (86 a 2 nmol/mg protein, Fig. 3 ).
The effect of amiloride on control acini was not clear cut in the first min of incubation, when the C1 content (76 + 3 nmol/mg protein) was similar ( p = 0.2) to that of cells not exposed to this inhibitor (Fig. 3) . At 5 min, however, the C1 content in the presence of amiloride (87 + 4 nmol/mg protein) was significantly lower ( p = 0.01) than in unexposed cells and steady state C1 content was 85 a 2 nmol/mg protein, a value significantly lower ( p = 0.001() than in cells not exposed to this inhibitor (Fig. 3) .
DIDS also significantly reduced the initial phase of C1 accumulation in acini of reserpine-treated rats (Fig. 3) . C1 content in the presence of this inhibitor was 44 a 3 nmol/mg protein after 2 min of incubation (p = 0.001 when compared to basal) (Fig.  3) . After this initial reduction in C1 content, however, the C1 content increased significantly in the acini of reserpine-treated rats exposed to DIDS, so that C1 content was 137 f 9 nmol/mg protein at 10 min and reached approximately 180 nmol/mg protein between 20 and 30 min of incubation. This was significantly higher (p = 0.001) than the steady state C1 in cells not exposed to DIDS (Fig. 3) . As in control acini, the effect of amiloride was not clear cut in the first min of incubation, when the C1 content (68 a 7 nmol/mg protein) was not significantly different (p = 0.2) from that observed in the absence of this inhibitor (65 a 4 nmol/mg protein, Fig. 3 ). C1 content at subsequent time points was, however, significantly smaller in the presence of amiloride and steady state C1 content was 75 f 1 nmol/mg protein, a value significantly smaller (p = 0.001) than in the absence of amiloride (Fig. 3) .
The data shown in Figures 1-3 for the initial phase of C1 accumulation were further analyzed by calculating rates of C1 accumulation between 1 and 5 min of incubation from the mean values shown in the figures. The reciprocals (l/rate) of the rates at the various time points were then plotted against time and the results are shown in Figure 4 . It can be seen that, in control acini, the rate of C1 accumulation is enhanced by acetylcholine (as suggested by the reduced l/rate relationship), whereas DIDS reduces it (as indicated by the increased reciprocal of the rate). As indicated by the data in Figure 3 , the effect of amiloride, however, is more clear in the latter part of the accumulation period (Fig. 4) . In acini isolated from reserpine-treated rats, the basal rate of early C1 accumulation was similar to that of control cells (Fig. 4) . In contrast to the latter, however, acetylcholine did not enhance the initial rate of C1 accumulation in cells of reserpine-treated animals (Fig. 4) . However, DIDS inhibited the initial rate of C1 accumulation in these cells (Fig. 4) , although the effect was somewhat different from that in control acini and became smaller with time (Fig. 4) . In view of the effect of this inhibitor on steady state C1 in the cells of the treated animals ( Fig. 3) , the results shown in Figure 4 suggest complexities in these cells relative to either the C1 transport systems responsible for C1 accumulation or their interaction with DIDS.
Effects of furosemide.
Furosemide is a loop diuretic that inhibits coupled cationlanion transport systems in epithelial cells; there is evidence that such a transport system is present in pancreatic cells (31) . We therefore investigated the effect of 1 mM furosemide on C1 accumulation in the acinar preparations. In control acini, furosemide had essentially no effect when added to the cell suspensions at time zero, but reduced C1 accumulation significantly when added 10 min before addition of tracer (Fig.  5) . Both the initial rate and the steady state accumulation were reduced in cells preincubated for this period of time with furosemide. The C1 content of the acini was 52 + 8 nmol/mg protein after 1 min of incubation in the presence of the inhibitor and 74 k 7 nmollmg protein after 5 min (Fig. 5) . The steady state C1 accumulation was 74 f 6 nmol/mg protein when furosemide was present in the medium for 10 min before tracer (Fig. 5 ). All these values are significantly smaller from the corresponding ones in the absence of furosemide (Fig. 5 ).
Furosemide also inhibited C1 accumulation in unstimulated acini of reserpine-treated rats. The effect was also evident, as in control acini, in both phases of Cl accumulation. The C1 content at 1 and 5 min was, respectively, 28 and 46 nmol/mg protein and the steady state content was 44 f 3 nmol/mg protein. These were significantly reduced in relation to the corresponding values in the absence of inhibitor.
Effect of transport inhibitors on acetylcholine-stimulated acini.
As shown in Table 1 , DIDS and amiloride inhibited C1 accumulation in control acini exposed to 1 pM acetylcholine. The inhibitory effect was evident in both the initial phase and the steady state phase of Cl accumulation (Table 1) . Furosemide also inhibited C1 accumulation in these control cells when added 10 min before tracer ( Table 1) . As in unstimulated cells (see Fig. 3 ), the effect of DIDS on C1 accumulation by acetylcholine-stimulated acini of reserpine-treated rats was biphasic (Table 1 ). An initial inhibition of Cl accumulation was followed by a significant increase in C1 content, which was 157% of the corresponding value in cells not exposed to DIDS between 10 and 30 min of incubation ( Table 1 ). The effect on the initial phase of accumulation was less than in control acini (Table I ). The inhibitory effect of furosemide on C1 accumulation was also significant in acini of reserpine-treated rats (Table I) , when the cells were exposed to this inhibitor for 10 min before secretagogue and tracer.
Effects of VIP and forskolin. We evaluated the effects of two other secretagogues on C1 accumulation in control acini. VIP acts in pancreatic epithelium through CAMP, whereas acetylcholine and caerulein use Ca2+ as their intracellular mediator (1 1, 14) . Forskolin is a disterpene derivative that activates adenylate cyclase and cAMP formation (22) . As shown in Figure 6 , neither VIP nor forskolin modified C1 accumulation in control acini. The initial and steady state phases of accumulation were essentially similar to those of cells not exposed to these substances.
DISCUSSION
The ion transport systems operating in pancreatic acinar cells have not been fully elucidated (14) , but studies with isolated, perfused tissues (1 3) and with isolated cells (23) suggest that, in the rat, they include a pair of functionally linked antiports in the basolateral cell membrane that exchange Na for H and C1 for HC03. The former is sensitive to amiloride and the latter to stilbene sulfonic acid derivatives such as DIDS (24, 25) . The results of our experiments with control acini can be interpreted as lending support to this model, as these inhibitors reduced C1 accumulation in both resting and acetylcholine-stimulated cells. Stilbene derivatives also inhibit, however, C1 conductances in several epithelial and non-epithelial cells (26) (27) (28) (29) and acetylcholine activates a C1 conductance pathway of fairly high permeability in pancreatic acinar cells (30) . In general, the anion exchanger is sensitive to lower doses of these inhibitors (i.e. in the pM range), whereas inhibition of C1 conductance pathways and other ion transport systems require higher stilbene concentrations (29) . Although the inhibitory effect of DIDS on C1 accumulation in control pancreatic acinar cells could result from blockade of the proposed Cl/HCO3 antiport, it could represent equally well effects on a C1 conductance pathway of the high concentrations of DIDS used. Amiloride also blocks cholinergic receptors in the pancreas (3 1) and its inhibition of C1 accumulation in control acini could be due to this effect, rather than to blockade of the proposed Na/H exchange.
Our results suggest that there are two distinct phases of C1 accumulation in rat pancreatic acini. The initial rate is stimulated by acetylcholine and by caerulein and is inhibited by DIDS. A steady state level of accumulation is also increased by secretagogues and is reduced to approximately the same extent by DIDS and by amiloride. The effect of amiloride on the initial rate of C1 accumulation is delayed but can be ascertained after 2-3 min of incubation (see Fig. 3) . The steady state level attained is likely to be related to the initial rate of accumulation and the effects of the various drugs on such level could result, therefore, from their effects on this initial rate and the resulting changes in cell C1 concentrations, cell volume, or both.
C1 accumulation is altered in pancreatic acini of reserpinetreated rats, as indicated by the failure of acetylcholine to increase C1 accumulation and by the large and sustained accumulation of C1 in the continued presence of DIDS. In contrast to control acini, no significant increase in the initial rate of C1 accumulation was seen with acetylcholine. This suggests that reserpine administration blocks the activation by the secretagogue of the transport mechanism responsible for early C1 accumulation. However, both basal and acetylcholine-stimulated early accumulation of C1 were inhibited by DIDS in the cells of the treated animals, although to a lesser extent than in control acini. Thus, the transport mechanisms in question retain a good portion of their DIDS sensitivity but lose their acetylcholine sensitivity after reserpine administration. This suggests complex changes in the transport mechanism or mechanisms responsible for early C1 accumulation after chronic reserpine. As DIDS can inhibit both C1 conductances and Cl/HC03 exchange (see above), either or both of these mechanisms may be affected in reserpine-treated rats. Analysis of dose-related responses to DIDS will help clarify the issue further.
The sustained increase in C1 accumulation in the continued presence of DIDS observed in the acini of reserpine-treated animals suggests an alteration in Cl transport mechanisms responsible for the maintenance of steady state C1 content. This could result from disturbances in C1 exit (efflux) or from a reversal in the direction of transport by a DIDS-sensitive C1/ HC03 exchange. The mechanisms of Cl emux in pancreatic acini are not clear, but there is evidence that they may involve a furosemide-sensitive Na, K, 2C1 cotransport system oriented in the opposite direction to that of salivary acini and other secretory epithelial (32) . The effects of preincubation with furosemide were similar in pancreatic acini of control and reserpine-treated rats. This argues against a disturbance in C1 exit in the latter cells, at least by way of the cotransport mechanism. A reversal in the direction of C1/HCOs exchange (moving C1 out of the cell) could occur, however, if there were changes after reserpine administration in intracellular HCO3, C1, or H (pH) concentrations or in metabolic functions critical for anion transport. Clearly, additional studies are necessary to explore these questions.
C1 accumulation was enhanced in control acini by secretagogues that use Ca2+ as their intracellular mediator, but not by those that act through cAMP (1 4). As previous evidence indicated that C1 accumulation in pancreatic acini is dependent on the presence of CaZ+ in the incubation medium (33) , it is possible that the alterations in C1 accumulation in acini of reserpinetreated rats is the result of a disturbance in the mediator role of Ca2+. This requires further study, but the alteration in C1 accumulation observed in this study can explain the reduced fluid secretion observed in vivo in reserpine-treated rats (4, 7, 8) , as C1 is required for secretagogue-induced fluid secretion in the rat (12) . Transcellular C1 transport is thought to be important also in human pancreatic acini (34) and alterations in pancreatic fluid and anion secretion are prominent in CF (35) . It is possible, therefore that these alterations are related to abnormal C1 transport in pancreatic acini of affected individuals, perhaps similar to those observed in this study on an experimental animal model of this disease.
The C1 transport defect in sweat glands (36) and airways (17, 18) of CF patients seems to be related, however, to a disturbance in a CAMP-mediated pathway regulating C1 transport. As C1 transport appears to be regulated by Ca2+, rather than by CAMP, in rat salivary (37) and pancreatic acinar cells (33) , a question arises about the relevance of the findings of this and the previous study on salivary cells of the reserpinized rat model. Ion channels and conductances are variously regulated by Ca2+ or by CAMP in exocrine and nonexocrine tissues (38) and one can speculate that the disturbance of C1 transport in exocrine glands of CF patients and of the reserpine rat model may be due to a regulatory malfunction by either of these intracellular messengers in accordance with the tissue involved. This may involve the interaction between membrane transport proteins and regulatory molecules activated by either Ca2+ or CAMP. Studies on the regulation of C1 transport in human salivary and pancreatic cells are clearly necessary to establish the validity of this speculation.
